WEBINAR: MASH & LIVER

AI-Powered Pathology for MASH & Liver Disease Research and Drug Development

Learn how to leverage and utilize the latest AI tools for MASH research & scale findings through the drug development lifecycle

Join us to discover the transformative role of AI-powered pathology in advancing drug development and providing unparalleled insights for MASH and liver disease.

In this webinar, our experts will delve into how AI-driven tools can provide high-resolution characterization of the inflammatory microenvironment and fibrotic microarchitecture in liver biopsies.

We'll introduce Liver Explore™, our cutting-edge tool designed to enhance understanding of disease biology and uncover insights into drug mechanisms of action. You’ll also have the chance to witness a live demonstration of Liver Explore™ in action with case studies highlighting how to leverage AI pathology in your research.

Watch On Demand

WHAT YOU WILL LEARN

Histological insights that can be uniquely captured by AI-powered pathology
An inside look at building AI tools specifically for liver disease research
Live demonstration of Liver Explore™
Case studies and guidance on leveraging AI-powered insights in MASH and liver disease
An overview of Liver Explore™’s versatility in MASH and non-MASH applications

Speakers

MODERATOR & PRESENTER
Christina Jayson, PhD
Associate Director of Product

KEYNOTE
Eric Walk, M.D.
Chief Medical Officer

Lara Murray, PhD
Senior Translational Scientist

Ylaine Gerardin, PhD
Principal Biomedical Data Scientist

Adam Stanford Moore, M.S.
Senior Machine Learning Engineer

Work with PathAI across the drug development lifecycle

Our mission is to improve patient outcomes with AI-powered pathology

PathAI has developed a comprehensive, scalable precision pathology solution for all stages of drug development. We bring together intelligent software platforms with robust AI algorithms leveraging data from our network of >550 US board-certified pathologists and library of millions of annotations and whole slide images.

Our content library

CASE STUDY

AI-Assisted Titer Selection in Early Assay Development

PathAI deployed IHC Explore on prostate cancer specimens stained with a novel, in-development assay
IHC Explore quantifies staining intensity at single-cell resolution, enabling rapid assay characterization and titer optimization
Continuous staining intensity measurement provides added value for next-generation biomarkers and precision medicine strategies